-
1
-
-
11144298761
-
Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi
-
Gandini S, Sera F, Cattaruzza MS, et al. Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 2005: 41: 28-44.
-
(2005)
Eur J Cancer
, vol.41
, pp. 28-44
-
-
Gandini, S.1
Sera, F.2
Cattaruzza, M.S.3
-
2
-
-
77949396613
-
Increased risk of second primary cancers after a diagnosis of melanoma
-
Bradford PT, Freedman DM, Goldstein AM, Tucker MA,. Increased risk of second primary cancers after a diagnosis of melanoma. Arch Dermatol 2010: 146: 265-272.
-
(2010)
Arch Dermatol
, vol.146
, pp. 265-272
-
-
Bradford, P.T.1
Freedman, D.M.2
Goldstein, A.M.3
Tucker, M.A.4
-
3
-
-
42649138270
-
Lessons from the skin - Cutaneous features of familial cancer
-
Winship IM, Dudding TE,. Lessons from the skin-cutaneous features of familial cancer. Lancet Oncol 2008: 9: 462-472.
-
(2008)
Lancet Oncol
, vol.9
, pp. 462-472
-
-
Winship, I.M.1
Dudding, T.E.2
-
4
-
-
27244435224
-
Population-based analysis of prognostic factors and survival in familial melanoma
-
Florell SR, Boucher KM, Garibotti G, et al. Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol 2005: 23: 7168-7177.
-
(2005)
J Clin Oncol
, vol.23
, pp. 7168-7177
-
-
Florell, S.R.1
Boucher, K.M.2
Garibotti, G.3
-
5
-
-
0025847504
-
Hereditary cutaneous malignant melanoma: A 20-year family update
-
Anderson DE, Badzioch MD,. Hereditary cutaneous malignant melanoma: a 20-year family update. Anticancer Res 1991: 11: 433-437.
-
(1991)
Anticancer Res
, vol.11
, pp. 433-437
-
-
Anderson, D.E.1
Badzioch, M.D.2
-
6
-
-
0032887878
-
Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: A consensus statement of the Melanoma Genetics Consortium
-
Kefford RF, Newton Bishop JA, Bergman W, Tucker MA,. Counseling and DNA testing for individuals perceived to be genetically predisposed to melanoma: a consensus statement of the Melanoma Genetics Consortium. J Clin Oncol 1999: 17: 3245-3251.
-
(1999)
J Clin Oncol
, vol.17
, pp. 3245-3251
-
-
Kefford, R.F.1
Newton Bishop, J.A.2
Bergman, W.3
Tucker, M.A.4
-
7
-
-
0027769876
-
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
-
Serrano M, Hannon GJ, Beach D,. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 1993: 366: 704-707.
-
(1993)
Nature
, vol.366
, pp. 704-707
-
-
Serrano, M.1
Hannon, G.J.2
Beach, D.3
-
8
-
-
0028931152
-
Inhibition of ras-induced proliferation and cellular transformation by p16INK4
-
Serrano M, Gomez-Lahoz E, DePinho RA, Beach D, Bar-Sagi D,. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 1995: 267: 249-252.
-
(1995)
Science
, vol.267
, pp. 249-252
-
-
Serrano, M.1
Gomez-Lahoz, E.2
Depinho, R.A.3
Beach, D.4
Bar-Sagi, D.5
-
9
-
-
0032549704
-
The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53
-
Pomerantz J, Schreiber-Agus N, Liegeois NJ, et al. The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998: 92: 713-723.
-
(1998)
Cell
, vol.92
, pp. 713-723
-
-
Pomerantz, J.1
Schreiber-Agus, N.2
Liegeois, N.J.3
-
10
-
-
0032549711
-
ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways
-
Zhang Y, Xiong Y, Yarbrough WG,. ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998: 92: 725-734.
-
(1998)
Cell
, vol.92
, pp. 725-734
-
-
Zhang, Y.1
Xiong, Y.2
Yarbrough, W.G.3
-
11
-
-
36949005417
-
DNA damage signalling guards against activated oncogenes and tumour progression
-
Bartek J, Bartkova J, Lukas J,. DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene 2007: 26: 7773-7779.
-
(2007)
Oncogene
, vol.26
, pp. 7773-7779
-
-
Bartek, J.1
Bartkova, J.2
Lukas, J.3
-
12
-
-
0030944985
-
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
-
Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW,. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 1997: 88: 593-602.
-
(1997)
Cell
, vol.88
, pp. 593-602
-
-
Serrano, M.1
Lin, A.W.2
McCurrach, M.E.3
Beach, D.4
Lowe, S.W.5
-
13
-
-
0029664339
-
Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma
-
Zuo L, Weger J, Yang Q, et al. Germline mutations in the p16INK4a binding domain of CDK4 in familial melanoma. Nat Genet 1996: 12: 97-99.
-
(1996)
Nat Genet
, vol.12
, pp. 97-99
-
-
Zuo, L.1
Weger, J.2
Yang, Q.3
-
14
-
-
33750567811
-
High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL
-
Goldstein AM, Chan M, Harland M, et al. High-risk melanoma susceptibility genes and pancreatic cancer, neural system tumors, and uveal melanoma across GenoMEL. Cancer Res 2006: 66: 9818-9828.
-
(2006)
Cancer Res
, vol.66
, pp. 9818-9828
-
-
Goldstein, A.M.1
Chan, M.2
Harland, M.3
-
15
-
-
27144522283
-
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample
-
Begg CB, Orlow I, Hummer AJ, et al. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst 2005: 97: 1507-1515.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1507-1515
-
-
Begg, C.B.1
Orlow, I.2
Hummer, A.J.3
-
16
-
-
80054121869
-
The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil
-
Bakos RM, Besch R, Zoratto GG, et al. The CDKN2A p.A148T variant is associated with cutaneous melanoma in Southern Brazil. Exp Dermatol 2011: 20: 890-893.
-
(2011)
Exp Dermatol
, vol.20
, pp. 890-893
-
-
Bakos, R.M.1
Besch, R.2
Zoratto, G.G.3
-
17
-
-
33750626267
-
MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk
-
Debniak T, Scott R, Masojc B, et al. MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk. Int J Cancer 2006: 119: 2597-2602.
-
(2006)
Int J Cancer
, vol.119
, pp. 2597-2602
-
-
Debniak, T.1
Scott, R.2
Masojc, B.3
-
18
-
-
21144439424
-
Role of the CDKN2A locus in patients with multiple primary melanomas
-
Puig S, Malvehy J, Badenas C, et al. Role of the CDKN2A locus in patients with multiple primary melanomas. J Clin Oncol 2005: 23: 3043-3051.
-
(2005)
J Clin Oncol
, vol.23
, pp. 3043-3051
-
-
Puig, S.1
Malvehy, J.2
Badenas, C.3
-
19
-
-
33745190720
-
The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations
-
Spica T, Portela M, Gerard B, et al. The A148T variant of the CDKN2A gene is not associated with melanoma risk in the French and Italian populations. J Invest Dermatol 2006: 126: 1657-1660.
-
(2006)
J Invest Dermatol
, vol.126
, pp. 1657-1660
-
-
Spica, T.1
Portela, M.2
Gerard, B.3
-
20
-
-
18744389747
-
An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele
-
Bertram CG, Gaut RM, Barrett JH, et al. An assessment of the CDKN2A variant Ala148Thr as a nevus/melanoma susceptibility allele. J Invest Dermatol 2002: 119: 961-965.
-
(2002)
J Invest Dermatol
, vol.119
, pp. 961-965
-
-
Bertram, C.G.1
Gaut, R.M.2
Barrett, J.H.3
-
21
-
-
0029863304
-
Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis
-
Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA,. Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996: 137: 1627-1633.
-
(1996)
Endocrinology
, vol.137
, pp. 1627-1633
-
-
Suzuki, I.1
Cone, R.D.2
Im, S.3
Nordlund, J.4
Abdel-Malek, Z.A.5
-
22
-
-
0345084470
-
Human pigmentation phenotype: A point mutation generates nonfunctional MSH receptor
-
Frandberg PA, Doufexis M, Kapas S, Chhajlani V,. Human pigmentation phenotype: a point mutation generates nonfunctional MSH receptor. Biochem Biophys Res Commun 1998: 245: 490-492.
-
(1998)
Biochem Biophys Res Commun
, vol.245
, pp. 490-492
-
-
Frandberg, P.A.1
Doufexis, M.2
Kapas, S.3
Chhajlani, V.4
-
23
-
-
0344603629
-
Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair
-
Schioth HB, Phillips SR, Rudzish R, Birch-Machin MA, Wikberg JE, Rees JL,. Loss of function mutations of the human melanocortin 1 receptor are common and are associated with red hair. Biochem Biophys Res Commun 1999: 260: 488-491.
-
(1999)
Biochem Biophys Res Commun
, vol.260
, pp. 488-491
-
-
Schioth, H.B.1
Phillips, S.R.2
Rudzish, R.3
Birch-Machin, M.A.4
Wikberg, J.E.5
Rees, J.L.6
-
24
-
-
79960912284
-
Melanocortin 1 receptor and risk of cutaneous melanoma: A meta-analysis and estimates of population burden
-
Williams PF, Olsen CM, Hayward NK, Whiteman DC,. Melanocortin 1 receptor and risk of cutaneous melanoma: a meta-analysis and estimates of population burden. Int J Cancer 2011: 129: 1730-1740.
-
(2011)
Int J Cancer
, vol.129
, pp. 1730-1740
-
-
Williams, P.F.1
Olsen, C.M.2
Hayward, N.K.3
Whiteman, D.C.4
-
25
-
-
0034837773
-
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations
-
Box NF, Duffy DL, Chen W, et al. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet 2001: 69: 765-773.
-
(2001)
Am J Hum Genet
, vol.69
, pp. 765-773
-
-
Box, N.F.1
Duffy, D.L.2
Chen, W.3
-
26
-
-
77951667623
-
MC1R variants increase melanoma risk in families with CDKN2A mutations: A meta-analysis
-
Fargnoli MC, Gandini S, Peris K, Maisonneuve P, Raimondi S,. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis. Eur J Cancer 2010: 46: 1413-1420.
-
(2010)
Eur J Cancer
, vol.46
, pp. 1413-1420
-
-
Fargnoli, M.C.1
Gandini, S.2
Peris, K.3
Maisonneuve, P.4
Raimondi, S.5
-
27
-
-
33747882661
-
MITF: Master regulator of melanocyte development and melanoma oncogene
-
Levy C, Khaled M, Fisher DE,. MITF: master regulator of melanocyte development and melanoma oncogene. Trends Mol Med 2006: 12: 406-414.
-
(2006)
Trends Mol Med
, vol.12
, pp. 406-414
-
-
Levy, C.1
Khaled, M.2
Fisher, D.E.3
-
28
-
-
82555187007
-
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma
-
Yokoyama S, Woods SL, Boyle GM, et al. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 2011: 480: 99-103.
-
(2011)
Nature
, vol.480
, pp. 99-103
-
-
Yokoyama, S.1
Woods, S.L.2
Boyle, G.M.3
-
29
-
-
82555205202
-
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma
-
Bertolotto C, Lesueur F, Giuliano S, et al. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 2011: 480: 94-98.
-
(2011)
Nature
, vol.480
, pp. 94-98
-
-
Bertolotto, C.1
Lesueur, F.2
Giuliano, S.3
-
30
-
-
84863615237
-
Essential elements of genetic cancer risk assessment, counseling, and testing: Updated recommendations of the National Society of Genetic Counselors
-
Riley BD, Culver JO, Skrzynia C, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors. J Genet Couns 2011: 21: 151-161.
-
(2011)
J Genet Couns
, vol.21
, pp. 151-161
-
-
Riley, B.D.1
Culver, J.O.2
Skrzynia, C.3
-
31
-
-
0028085975
-
Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus
-
Kamb A, Shattuck-Eidens D, Eeles R, et al. Analysis of the p16 gene (CDKN2) as a candidate for the chromosome 9p melanoma susceptibility locus. Nat Genet 1994: 8: 23-26.
-
(1994)
Nat Genet
, vol.8
, pp. 23-26
-
-
Kamb, A.1
Shattuck-Eidens, D.2
Eeles, R.3
-
33
-
-
53349090631
-
CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families
-
Aspinwall LG, Leaf SL, Dola ER, Kohlmann W, Leachman SA,. CDKN2A/p16 genetic test reporting improves early detection intentions and practices in high-risk melanoma families. Cancer Epidemiol Biomarkers Prev 2008: 17: 1510-1519.
-
(2008)
Cancer Epidemiol Biomarkers Prev
, vol.17
, pp. 1510-1519
-
-
Aspinwall, L.G.1
Leaf, S.L.2
Dola, E.R.3
Kohlmann, W.4
Leachman, S.A.5
-
34
-
-
2142645979
-
Clinical germline genetic testing for melanoma
-
Hansen CB, Wadge LM, Lowstuter K, Boucher K, Leachman SA,. Clinical germline genetic testing for melanoma. Lancet Oncol 2004: 5: 314-319.
-
(2004)
Lancet Oncol
, vol.5
, pp. 314-319
-
-
Hansen, C.B.1
Wadge, L.M.2
Lowstuter, K.3
Boucher, K.4
Leachman, S.A.5
-
35
-
-
0033818195
-
Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma
-
Tsao H, Zhang X, Kwitkiwski K, Finkelstein DM, Sober AJ, Haluska FG,. Low prevalence of germline CDKN2A and CDK4 mutations in patients with early-onset melanoma. Arch Dermatol 2000: 136: 1118-1122.
-
(2000)
Arch Dermatol
, vol.136
, pp. 1118-1122
-
-
Tsao, H.1
Zhang, X.2
Kwitkiwski, K.3
Finkelstein, D.M.4
Sober, A.J.5
Haluska, F.G.6
-
36
-
-
70249098475
-
Selection criteria for genetic assessment of patients with familial melanoma
-
Leachman SA, Carucci J, Kohlmann W, et al. Selection criteria for genetic assessment of patients with familial melanoma. J Am Acad Dermatol 2009: 61: 677-684.
-
(2009)
J Am Acad Dermatol
, vol.61
, pp. 677-684
-
-
Leachman, S.A.1
Carucci, J.2
Kohlmann, W.3
-
37
-
-
0042522711
-
Pancreatic carcinoma surveillance in patients with familial melanoma
-
Parker JF, Florell SR, Alexander A, DiSario JA, Shami PJ, Leachman SA,. Pancreatic carcinoma surveillance in patients with familial melanoma. Arch Dermatol 2003: 139: 1019-1025.
-
(2003)
Arch Dermatol
, vol.139
, pp. 1019-1025
-
-
Parker, J.F.1
Florell, S.R.2
Alexander, A.3
Disario, J.A.4
Shami, P.J.5
Leachman, S.A.6
-
38
-
-
33847282821
-
Features associated with germline CDKN2A mutations: A GenoMEL study of melanoma-prone families from three continents
-
Goldstein AM, Chan M, Harland M, et al. Features associated with germline CDKN2A mutations: a GenoMEL study of melanoma-prone families from three continents. J Med Genet 2007: 44: 99-106.
-
(2007)
J Med Genet
, vol.44
, pp. 99-106
-
-
Goldstein, A.M.1
Chan, M.2
Harland, M.3
-
39
-
-
0037954289
-
Dermatologist detection and skin self-examination are associated with thinner melanomas: Results from a survey of the Italian Multidisciplinary Group on Melanoma
-
Carli P, De Giorgi V, Palli D, et al. Dermatologist detection and skin self-examination are associated with thinner melanomas: results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 2003: 139: 607-612.
-
(2003)
Arch Dermatol
, vol.139
, pp. 607-612
-
-
Carli, P.1
De Giorgi, V.2
Palli, D.3
-
40
-
-
82955192301
-
Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma
-
Salerni G, Carrera C, Lovatto L, et al. Benefits of total body photography and digital dermatoscopy ("two-step method of digital follow-up") in the early diagnosis of melanoma in patients at high risk for melanoma. J Am Acad Dermatol 2012: 67: e17-27.
-
(2012)
J Am Acad Dermatol
, vol.67
-
-
Salerni, G.1
Carrera, C.2
Lovatto, L.3
-
41
-
-
58149229703
-
Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families
-
de Snoo FA, Bishop DT, Bergman W, et al. Increased risk of cancer other than melanoma in CDKN2A founder mutation (p16-Leiden)-positive melanoma families. Clin Cancer Res 2008: 14: 7151-7157.
-
(2008)
Clin Cancer Res
, vol.14
, pp. 7151-7157
-
-
De Snoo, F.A.1
Bishop, D.T.2
Bergman, W.3
-
42
-
-
0037134702
-
Geographical variation in the penetrance of CDKN2A mutations for melanoma
-
Bishop DT, Demenais F, Goldstein AM, et al. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J Natl Cancer Inst 2002: 94: 894-903.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 894-903
-
-
Bishop, D.T.1
Demenais, F.2
Goldstein, A.M.3
-
43
-
-
65649118981
-
Melanoma genetics: An update on risk-associated genes
-
vii
-
Udayakumar D, Tsao H,. Melanoma genetics: an update on risk-associated genes. Hematol Oncol Clin North Am 2009: 23: 415-429, vii.
-
(2009)
Hematol Oncol Clin North Am
, vol.23
, pp. 415-429
-
-
Udayakumar, D.1
Tsao, H.2
-
44
-
-
84856641278
-
A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q
-
Teerlink C, Farnham J, Allen-Brady K, et al. A unique genome-wide association analysis in extended Utah high-risk pedigrees identifies a novel melanoma risk variant on chromosome arm 10q. Hum Genet 2012: 131: 77-85.
-
(2012)
Hum Genet
, vol.131
, pp. 77-85
-
-
Teerlink, C.1
Farnham, J.2
Allen-Brady, K.3
-
45
-
-
80053640638
-
Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma
-
Hoiom V, Tuominen R, Hansson J,. Genome-wide linkage analysis of Swedish families to identify putative susceptibility loci for cutaneous malignant melanoma. Genes Chromosomes Cancer 2011: 50: 1076-1084.
-
(2011)
Genes Chromosomes Cancer
, vol.50
, pp. 1076-1084
-
-
Hoiom, V.1
Tuominen, R.2
Hansson, J.3
-
46
-
-
79956078755
-
Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit
-
Salerni G, Lovatto L, Carrera C, Puig S, Malvehy J,. Melanomas detected in a follow-up program compared with melanomas referred to a melanoma unit. Arch Dermatol 2011: 147: 549-555.
-
(2011)
Arch Dermatol
, vol.147
, pp. 549-555
-
-
Salerni, G.1
Lovatto, L.2
Carrera, C.3
Puig, S.4
Malvehy, J.5
|